Year |
Citation |
Score |
2023 |
Weathered C, Bardehle S, Yoon C, Kumar N, Leyns CEG, Kennedy ME, Bloomingdale P, Pienaar E. Microglial Roles in Alzheimer's Disease: An Agent-Based Model to Elucidate Microglial Spatiotemporal Response to Beta-Amyloid. Cpt: Pharmacometrics & Systems Pharmacology. PMID 38078626 DOI: 10.1002/psp4.13095 |
0.735 |
|
2023 |
Cody JW, Ellis-Connell AL, O'Connor SL, Pienaar E. Mathematical modeling indicates that regulatory inhibition of CD8+ T cell cytotoxicity can limit efficacy of IL-15 immunotherapy in cases of high pre-treatment SIV viral load. Plos Computational Biology. 19: e1011425. PMID 37616311 DOI: 10.1371/journal.pcbi.1011425 |
0.727 |
|
2023 |
Liu X, Husby M, Stahelin RV, Pienaar E. Evaluation of Fendiline Treatment in VP40 System with Nucleation-Elongation Process: A Computational Model of Ebola Virus Matrix Protein Assembly. Biorxiv : the Preprint Server For Biology. PMID 37577722 DOI: 10.1101/2023.08.03.551833 |
0.32 |
|
2023 |
Weathered C, Wei N, Pienaar E. Reduced macrophage killing of M. avium drives infection risk in post-menopausal patients. Tuberculosis (Edinburgh, Scotland). 139: 102304. PMID 36682272 DOI: 10.1016/j.tube.2023.102304 |
0.758 |
|
2022 |
Weathered C, Pennington K, Escalante P, Pienaar E. Agent-based model indicates chemoattractant signaling caused by Mycobacterium avium biofilms in the lung airway increases bacterial loads by spatially diverting macrophages. Tuberculosis (Edinburgh, Scotland). 138: 102300. PMID 36621288 DOI: 10.1016/j.tube.2022.102300 |
0.759 |
|
2022 |
Hoerter A, Arnett E, Schlesinger LS, Pienaar E. Systems biology approaches to investigate the role of granulomas in TB-HIV coinfection. Frontiers in Immunology. 13: 1014515. PMID 36405707 DOI: 10.3389/fimmu.2022.1014515 |
0.681 |
|
2022 |
Liu X, Pappas EJ, Husby ML, Motsa BB, Stahelin RV, Pienaar E. Mechanisms of phosphatidylserine influence on viral production: a computational model of Ebola virus matrix protein assembly. The Journal of Biological Chemistry. 102025. PMID 35568195 DOI: 10.1016/j.jbc.2022.102025 |
0.303 |
|
2022 |
Pennington KM, Katta R, Weathered C, Pienaar E, Escalante P. Characteristics and outcomes of anti-mycobacterial therapy compared to no anti-mycobacterial therapy for NTM pulmonary disease. Respiratory Medicine. 197: 106829. PMID 35364522 DOI: 10.1016/j.rmed.2022.106829 |
0.719 |
|
2021 |
Weathered C, Pennington K, Escalante P, Pienaar E. The Role of Biofilms, Bacterial Phenotypes, and Innate Immune Response in Mycobacterium avium Colonization to Infection. Journal of Theoretical Biology. 110949. PMID 34717938 DOI: 10.1016/j.jtbi.2021.110949 |
0.772 |
|
2021 |
Cody JW, Ellis-Connell AL, O'Connor SL, Pienaar E. Mathematical modeling of N-803 treatment in SIV-infected non-human primates. Plos Computational Biology. 17: e1009204. PMID 34319980 DOI: 10.1371/journal.pcbi.1009204 |
0.734 |
|
2019 |
Elkington P, Lerm M, Kapoor N, Mahon R, Pienaar E, Huh D, Kaushal D, Schlesinger LS. In Vitro Granuloma Models of Tuberculosis: Potential and Challenges. The Journal of Infectious Diseases. PMID 30929010 DOI: 10.1093/Infdis/Jiz020 |
0.373 |
|
2019 |
Sarathy J, Blanc L, Alvarez-Cabrera N, O'Brien P, Dias-Freedman I, Mina M, Zimmerman M, Kaya F, Liang HH, Prideaux B, Dietzold J, Salgame P, Savic R, Linderman J, Kirschner D, ... Pienaar E, et al. Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations. Antimicrobial Agents and Chemotherapy. PMID 30803965 DOI: 10.1128/Aac.02516-18 |
0.305 |
|
2018 |
Pienaar E, Linderman JJ, Kirschner DE. Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas. Plos One. 13: e0196322. PMID 29746491 DOI: 10.1371/Journal.Pone.0196322 |
0.306 |
|
2017 |
Kirschner D, Pienaar E, Marino S, Linderman JJ. A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment. Current Opinion in Systems Biology. 3: 170-185. PMID 30714019 DOI: 10.1016/J.Coisb.2017.05.014 |
0.413 |
|
2017 |
Warsinske HC, Pienaar E, Linderman JJ, Mattila JT, Kirschner DE. Deletion of TGF-β1 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model. Frontiers in Immunology. 8: 1843. PMID 29326718 DOI: 10.3389/Fimmu.2017.01843 |
0.387 |
|
2017 |
Cicchese JM, Pienaar E, Kirschner DE, Linderman JJ. Applying optimization algorithms to tuberculosis antibiotic treatment regimens. Cellular and Molecular Bioengineering. 10: 523-535. PMID 29276546 DOI: 10.1007/S12195-017-0507-6 |
0.314 |
|
2017 |
Pienaar E, Sarathy J, Prideaux B, Dietzold J, Dartois V, Kirschner DE, Linderman JJ. Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach. Plos Computational Biology. 13: e1005650. PMID 28817561 DOI: 10.1371/Journal.Pcbi.1005650 |
0.358 |
|
2016 |
Pienaar E, Matern WM, Linderman JJ, Bader JS, Kirschner DE. Multi-scale model of Mycobacterium tuberculosis infection maps metabolite and gene perturbations to granuloma sterilization predictions. Infection and Immunity. PMID 26975995 DOI: 10.1128/Iai.01438-15 |
0.368 |
|
2015 |
Pienaar E, Dartois V, Linderman JJ, Kirschner DE. In silico evaluation and exploration of antibiotic tuberculosis treatment regimens. Bmc Systems Biology. 9: 79. PMID 26578235 DOI: 10.1186/S12918-015-0221-8 |
0.372 |
|
2015 |
Linderman JJ, Cilfone NA, Pienaar E, Gong C, Kirschner DE. A multi-scale approach to designing therapeutics for tuberculosis. Integrative Biology : Quantitative Biosciences From Nano to Macro. 7: 591-609. PMID 25924949 DOI: 10.1039/C4Ib00295D |
0.36 |
|
2015 |
Pienaar E, Cilfone NA, Lin PL, Dartois V, Mattila JT, Butler JR, Flynn JL, Kirschner DE, Linderman JJ. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment. Journal of Theoretical Biology. 367: 166-79. PMID 25497475 DOI: 10.1016/J.Jtbi.2014.11.021 |
0.411 |
|
2014 |
Raffetseder J, Pienaar E, Blomgran R, Eklund D, Patcha Brodin V, Andersson H, Welin A, Lerm M. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility. Plos One. 9: e112426. PMID 25386849 DOI: 10.1371/Journal.Pone.0112426 |
0.364 |
|
2014 |
Pienaar E, Lerm M. A mathematical model of the initial interaction between Mycobacterium tuberculosis and macrophages. Journal of Theoretical Biology. 342: 23-32. PMID 24112967 DOI: 10.1016/J.Jtbi.2013.09.029 |
0.397 |
|
2014 |
Pienaar E, Lerm M. Erratum to “A mathematical model of the initial interaction between Mycobacterium tuberculosis and macrophages” [J. Theoret. Biol. 342 (2014) 23–32] Journal of Theoretical Biology. 349: 172. DOI: 10.1016/J.Jtbi.2014.02.007 |
0.31 |
|
2014 |
Cilfone NA, Pienaar E, Kirschner DE, Linderman JJ. Computational Modeling of Granuloma Formation in Tuberculosis Yields Insights into both Infection and Treatment Biophysical Journal. 106: 644a. DOI: 10.1016/J.Bpj.2013.11.3565 |
0.418 |
|
2012 |
Viljoen S, Pienaar E, Viljoen HJ. A state-time epidemiology model of tuberculosis: importance of re-infection. Computational Biology and Chemistry. 36: 15-22. PMID 22340441 DOI: 10.1016/J.Compbiolchem.2011.11.003 |
0.597 |
|
2011 |
Louw TM, Booth CS, Pienaar E, Termaat JR, Whitney SE, Viljoen HJ. Experimental Validation of a Fundamental Model for PCR Efficiency. Chemical Engineering Science. 66: 1783-1789. PMID 21822325 DOI: 10.1016/J.Ces.2011.01.029 |
0.745 |
|
2011 |
Louw TM, Whitney SE, Termaat JR, Pienaar E, Viljoen HJ. Oligonucleotide optimization for DNA synthesis Aiche Journal. 57: 1912-1918. DOI: 10.1002/Aic.12410 |
0.732 |
|
2010 |
Booth CS, Pienaar E, Termaat JR, Whitney SE, Louw TM, Viljoen HJ. Efficiency of the Polymerase Chain Reaction. Chemical Engineering Science. 65: 4996-5006. PMID 21799540 DOI: 10.1016/J.Ces.2010.05.046 |
0.742 |
|
2010 |
Pienaar E, Fluitt AM, Whitney SE, Freifeld AG, Viljoen HJ. A model of tuberculosis transmission and intervention strategies in an urban residential area. Computational Biology and Chemistry. 34: 86-96. PMID 20381428 DOI: 10.1016/J.Compbiolchem.2010.03.003 |
0.624 |
|
2009 |
Valente W, Pienaar E, Fast A, Fluitt A, Whitney S, Fenton R, Barletta R, Chacon O, Viljoen H. A Kinetic Study of In Vitro Lysis of Mycobacterium smegmatis. Chemical Engineering Science. 64: 1944-1952. PMID 21451732 DOI: 10.1016/J.Ces.2008.12.015 |
0.632 |
|
2009 |
Pienaar E, Whitney SE, Viljoen HJ, van Rensburg NF. A model of the complex response of Staphylococcus aureus to methicillin. Journal of Theoretical Biology. 257: 438-45. PMID 19135063 DOI: 10.1016/J.Jtbi.2008.12.003 |
0.61 |
|
2008 |
Mamedov TG, Pienaar E, Whitney SE, TerMaat JR, Carvill G, Goliath R, Subramanian A, Viljoen HJ. A fundamental study of the PCR amplification of GC-rich DNA templates. Computational Biology and Chemistry. 32: 452-7. PMID 18760969 DOI: 10.1016/J.Compbiolchem.2008.07.021 |
0.595 |
|
2008 |
Pienaar E, Viljoen HJ. The tri-frame model. Journal of Theoretical Biology. 251: 616-27. PMID 18237749 DOI: 10.1016/J.Jtbi.2007.12.003 |
0.576 |
|
2007 |
Fluitt A, Pienaar E, Viljoen H. Ribosome kinetics and aa-tRNA competition determine rate and fidelity of peptide synthesis. Computational Biology and Chemistry. 31: 335-46. PMID 17897886 DOI: 10.1016/J.Compbiolchem.2007.07.003 |
0.571 |
|
2006 |
Pienaar E, Theron M, Nelson M, Viljoen HJ. A quantitative model of error accumulation during PCR amplification. Computational Biology and Chemistry. 30: 102-11. PMID 16412692 DOI: 10.1016/J.Compbiolchem.2005.11.002 |
0.58 |
|
Show low-probability matches. |